After analyzing the tumor sizes and weight, the results showed that overexpression of METTL3 significantly potentiated allograft growth of cervical cancer in vivo, which increased both tumor sizes and tumor weight (Figure 7A–C), confirming the cancer‐promoting role of METTL3 in cancer progression. Here, METTL3 is linked to cervical cancer.